Comprehensive Analysis of the Monoclonal Antibodies In Veterinary Health Market 2025-2034: Growth Rates, Trends, and Future Opportunities
Get 20% OFF on all 2025 Global Market Reports until March 31st! Apply code FY25SAVE and grab your savings today!
How has the monoclonal antibodies in veterinary health market grown over the years?
The size of the monoclonal antibodies market in veterinary health has seen a rapid expansion in the past few years. The market, which was worth $0.8 billion in 2024, is expected to grow to $0.92 billion in 2025, with a compound annual growth rate (CAGR) of 15.2%. The spectacular growth throughout the historic period can be linked to several factors including the rise in pet ownership across the globe, a surge in chronic disease cases among animals, an uptick in pet adoption rates, and growing health awareness among pet owners.
What Is the forecasted market size and growth rate for the monoclonal antibodies in veterinary health market?
The market size of monoclonal antibodies in veterinary health is predicted to experience a quick expansion in the upcoming years, reaching $1.61 billion in 2029 with a compound annual growth rate (CAGR) of 15.0%. This projected growth across the forecast period can be credited to a rise in pet populations, an increase in expenditure on pets, a growing rate of canine atopic dermatitis, an amplified demand for sophisticated veterinary healthcare, and an escalating focus on animal health. Key trends anticipated during the forecast period include developments in biotechnology and research, progressions in genetic engineering, innovative therapies, advancements in therapy based on antibodies, and technological progress in antibody engineering.
Get your monoclonal antibodies in veterinary health market report here!
What are the major factors driving growth in the monoclonal antibodies in veterinary health market?
The growth of the monoclonal antibodies in the veterinary health market is likely to be fueled by increasing incidents of animal diseases. These rise in diseases can be attributed to intensified farming methods that amplify the risk of infectious diseases and global climate changes that broaden the disease carriers such as ticks and mosquitoes. Monoclonal antibodies play a crucial role in curing animal diseases as they specially target the pathogens or proteins that play a role in disease development, providing precise and efficient remedies. For example, a GOV.UK report published in June 2024 indicated a 5% increase in animals being put down due to TB incidents in England, with a total of 21,298, and a 17% increase in Wales, with a total of 11,197, between April 2023 and March 2024. This surge in animal diseases is stimulating the expansion of the monoclonal antibodies in the veterinary health market.
What key areas define the segmentation of the global monoclonal antibodies in veterinary health Market?
The monoclonal antibodies in veterinary health market covered in this report is segmented –
1) By Animal Type: Dogs, Other Animal Types
2) By Application: Dermatology, Pain, Other Applications
3) By End-User: Veterinary Hospitals, Other End-Users
Subsegments:
1) By Dogs: Canine Infectious Diseases, Canine Cancer Treatment, Canine Autoimmune Disorders, Canine Allergies
2) By Other Animal Types: Cats, Horses, Cattle, Swine, Poultry, Aquatic Animals, Small Mammals
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20575&type=smp
What are the top market players propelling the growth of the monoclonal antibodies in veterinary health industry?
Major companies operating in the monoclonal antibodies in veterinary health market are Sanofi S.A., Bristol-Myers Squibb Company, GlaxoSmithKline plc (GSK), Amgen Inc., Boehringer Ingelheim International GmbH, Regeneron Pharmaceuticals Inc., Zoetis Inc., MSD Animal Health, Elanco Animal Health Incorporated, Bio-Rad Laboratories Inc., Eli Lilly and Company, GenScript Biotech Corporation, Abcam plc, Heska Corporation, Neogen Corporation, iNova Pharmaceuticals, Ceva Santé Animale S.A., Biogénesis Bagó S.A., TransGen Biotech Co. Ltd., AbCellera Biologics Inc., Areteia Therapeutics Inc., Esco Aster Pte Ltd, PetMedix Ltd., Vaxine Pty Ltd
What are the key trends shaping the future of the monoclonal antibodies in veterinary health market?
Leading corporations within the monoclonal antibodies in veterinary health market are steering towards the creation of novel therapeutic solutions in veterinary health, among them being the anti-NGF monoclonal antibody treatment, specifically designed to alleviate chronic pain and inflammation in animals. This therapeutic process works by focusing on and limiting nerve growth factor (NGF) in order to diminish the suffering of animals from chronic pain. An example of this was noted in May 2023 when Zoetis, a US animal health company, was given FDA clearance for Librela (bedinvetmab injection) – the first of its kind monoclonal antibody treatment which moderates pain related to osteoarthritis (OA) in dogs, applied through a monthly injection, and Apoquel Chewable, a unique chewable medication tailored to manage allergic itch and inflammation in dogs a year old and above. Librela is a monoclonal antibody that works to target and suppress nerve growth factor (NGF), preventing the brain from receiving pain signals and thereby lessening the pain felt by dogs with osteoarthritis. The introduction of Librela symbolises a significant progress in the field of veterinary pain management by offering a creative solution to chronic pain in dogs.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20575
What regions are dominating the monoclonal antibodies in veterinary health market growth?
North America was the largest region in the monoclonal antibodies in veterinary health market in 2024. The regions covered in the monoclonal antibodies in veterinary health market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Pain Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-pain-management-global-market-report
Veterinary Reference Laboratory Global Market Report 2025
Veterinary Radiosurgery System Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
